Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.77 |
| ▸ | CA2 | P00918 | 6/20 | 0.77 |
| ▸ | HPGD | P15428 | 4/20 | 0.77 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.77 |
| ▸ | CA4 | P22748 | 4/20 | 0.77 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.77 |
| ▸ | LMNA | P02545 | 3/20 | 0.77 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.77 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.77 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.77 |
| ▸ | CA12 | O43570 | 3/20 | 0.77 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.77 |
| ▸ | EGFR | P00533 | 2/20 | 0.77 |
| ▸ | FYN | P06241 | 2/20 | 0.77 |
| ▸ | MMP9 | P14780 | 2/20 | 0.77 |
| ▸ | RECQL | P46063 | 2/20 | 0.77 |
| ▸ | NPC1 | O15118 | 2/20 | 0.77 |
| ▸ | MAPT | P10636 | 2/20 | 0.77 |
| ▸ | CA3 | P07451 | 2/20 | 0.77 |
| ▸ | GMNN | O75496 | 1/20 | 0.77 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Catechol SCHEMBL28985421 | 1.00 | ALDH1A1 (0.77) | ALDH1A1CA2HPGDTDP1CA4 | |
| Catechol SCHEMBL11672589 | 0.88 | ALDH1A1 (1.00) | ALDH1A1CA2HPGDTDP1CA4 | |
| Catechol SCHEMBL29352716 | 0.88 | — | — | |
| Catechol SCHEMBL30088487 | 0.88 | — | — | |
| Catechol SCHEMBL367675 | 0.88 | ALDH1A1 (1.00) | ALDH1A1CA2HPGDTDP1CA4 | |
| Catechol SCHEMBL18351 | 0.88 | — | — | |
| Catechol SCHEMBL30944695 | 0.88 | ALDH1A1 (1.00) | ALDH1A1CA2HPGDTDP1CA4 | |
| Catechol SCHEMBL25313512 | 0.84 | — | — | |
| Catechol SCHEMBL5706397 | 0.84 | ALDH1A1 (0.91) | ALDH1A1CA2HPGDTDP1CA4 | |
| Catechol SCHEMBL16393831 | 0.84 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240408272-A1 | BIO-ABSORBABLE DISPERSIBLE RAPIDLY DEPLOYABLE WOUND INTERFACE | KCI MANUFACTURING UNLIMITED COMPANY (IE) | 2024-12-12 | — | — | US | claimed |
| CN-118994216-A | 2-Boron ester-norbornene and use thereof and polymer containing alkenyl boron ester in main chain | 北京大学 | 2024-11-22 | — | — | CN | claimed |
| WO-2022234444-A1 | BIO-ABSORBABLE DISPERSIBLE RAPIDLY DEPLOYABLE WOUND INTERFACE | KCI MANUFACTURING UNLIMITED COMPANY (IE) | 2022-11-10 | — | — | WO | claimed |
| US-20240408272-A1 | BIO-ABSORBABLE DISPERSIBLE RAPIDLY DEPLOYABLE WOUND INTERFACE | KCI MANUFACTURING UNLIMITED COMPANY (IE) | 2024-12-12 | — | — | US | disclosed |
| US-11814393-B2 | Substituted guanidine compounds | UBE CORPORATION (JP) | 2023-11-14 | — | — | US | disclosed |
| CN-115417999-B | One-dimensional polyrotaxane constructed based on coordination boron-nitrogen bond, and preparation method and application thereof | 浙江大学杭州国际科创中心 | 2023-07-07 | — | — | CN | disclosed |
| WO-2022249992-A1 | PRODUCTION METHOD FOR BIPYRIDINE DERIVATIVE, PRODUCTION METHOD FOR MACROCYCLIC COMPOUND, PRODUCTION METHOD FOR METAL COMPLEX INCLUDING MACROCYCLIC COMPOUND AS LIGAND, METAL COMPLEX, ELECTRODE FOR AIR BATTERY, AND AIR BATTERY | 住友化学株式会社 | 2022-12-01 | — | — | WO | disclosed |
| WO-2022234444-A1 | BIO-ABSORBABLE DISPERSIBLE RAPIDLY DEPLOYABLE WOUND INTERFACE | KCI MANUFACTURING UNLIMITED COMPANY (IE) | 2022-11-10 | — | — | WO | disclosed |
| US-20220315599-A1 | SUBSTITUTED GUANIDINE COMPOUNDS | UBE CORP (JP) | 2022-10-06 | — | — | US | disclosed |
| US-11396514-B2 | Substituted guanidine compounds | UBE CORPORATION | 2022-07-26 | — | — | US | disclosed |
| EP-3564230-B1 | SUBSTITUTED GUANIDINE COMPOUND | UBE INDUSTRIES (JP) | 2022-02-09 | — | — | EP | disclosed |
| US-6884482-B2 | Fuel container having excellent gasoline barrier properties | KURARAY CO., LTD. (JP) | 2005-04-26 | — | — | US | disclosed |
| US-20040220366-A1 | Block copolymer and thermoplastic resin composition | KURARAY CO., LTD. (JP) | 2004-11-04 | — | — | US | disclosed |
| US-20040076780-A1 | Method of producing a shaped article having excellent barrier properties | KURARAY CO. LTD (JP) | 2004-04-22 | — | — | US | disclosed |
| EP-1369438-A1 | BLOCK COPOLYMER AND THERMOPLASTIC RESIN COMPOSITION | Kuraray Co., Ltd., Kurashiki Plant (JP) | 2003-12-10 | — | — | EP | disclosed |
| US-20030004165-A1 | Polyazanaphthalene compounds and pharmaceutical use thereof | AJINOMOTO CO. INC (JP) | 2003-01-02 | — | — | US | disclosed |
| US-20020176955-A1 | Fuel container having excellent gasoline barrier properties | EVAL COMPANY OF AMERICA | 2002-11-28 | — | — | US | disclosed |
| US-20020172788-A1 | Method of producing a shaped article having excellent barrier properties | KURARAY CO., LTD. (JP) | 2002-11-21 | — | — | US | disclosed |
| EP-1245381-A1 | Fuel container having excellent gasoline barrier properties | Kuraray Co., Ltd. (JP) | 2002-10-02 | — | — | EP | disclosed |
| EP-1166892-A2 | A method of producing a shaped article having excellent barrier properties | Kuraray Co., Ltd. (JP) | 2002-01-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030004165-A1 | Polyazanaphthalene compounds and pharmaceutical use thereof | MMP1, TNF, MMP12 | ALDH1A1 998/4885CA2 963/4885HPGD 115/4885 |
| US-20220315599-A1 | SUBSTITUTED GUANIDINE COMPOUNDS | GMPS, PDE3B, GUCY1A2 | ALDH1A1 557/4885CA2 1116/4885HPGD 924/4885 |
| US-11814393-B2 | Substituted guanidine compounds | GMPS, PDE3B, GUCY1A2 | ALDH1A1 557/4885CA2 1116/4885HPGD 924/4885 |
| US-11396514-B2 | Substituted guanidine compounds | GMPS, PDE3B, GUCY1A2 | ALDH1A1 557/4885CA2 1116/4885HPGD 924/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.